News & Updates

Show Multimedia Only

Healthy low-carb, low-fat diets may lower CHD risk

09 Jun 2026

The healthy versions of low-carbohydrate (LCD) and low-fat diets (LFD) appear to reduce the risk of coronary heart disease (CHD), suggests a study.

Healthy low-carb, low-fat diets may lower CHD risk

09 Jun 2026

Daraxonrasib makes history in one of the deadliest cancers

09 Jun 2026 by

Daraxonrasib—an oral, potent RAS(ON) multi-selective, tri-complex inhibitor—demonstrates unprecedented survival benefits in individuals with previously treated metastatic pancreatic adenocarcinoma (mPDAC) in the landmark phase III RASolute 302 study.

Daraxonrasib makes history in one of the deadliest cancers

09 Jun 2026

Oral semaglutide provides limited benefit in individuals with early AD

09 Jun 2026

The use of oral semaglutide does not reduce the speed of clinical progression in individuals with early Alzheimer's disease (AD), according to the results to two phase III trials.

Oral semaglutide provides limited benefit in individuals with early AD

09 Jun 2026

Product Highlight - Cefuroxime axetil (Cefudyne)

09 Jun 2026

Powder for oral suspension 250 mg/5 mL x 70 mL

Product Highlight - Cefuroxime axetil (Cefudyne)

09 Jun 2026

Product Highlight - Xylometazoline HCl (Xylomet)

09 Jun 2026

Nasal spray 0.1% x 15 mL

Product Highlight - Xylometazoline HCl (Xylomet)

09 Jun 2026

Product Highlight - Prednisolone (Predzone)

09 Jun 2026

Syrup 20 mg/5 mL

Product Highlight - Prednisolone (Predzone)

09 Jun 2026

Product Highlight - Prednisolone (Neopred)

09 Jun 2026

Syrup 20 mg/5 mL x 60 mL

Product Highlight - Prednisolone (Neopred)

09 Jun 2026

Product Highlight - Multivitamins + Iron (Appetite OB)

09 Jun 2026

Capsule

Product Highlight - Multivitamins + Iron (Appetite OB)

09 Jun 2026

First-in-class P-CAB a game-changer in H. pylori eradication

09 Jun 2026 by

Vonoprazan, a first-in-class potassium-competitive acid blocker (P-CAB), produces a sustained gastric acid suppression effect that is both more profound and more rapid than that of proton pump inhibitors (PPIs), making it an essential component of first-line (1L) and second-line (2L) therapy for Helicobacter pylori eradication, according to Professor Takashi Kawai of Tokyo Medical University Hospital, Tokyo, Japan.

First-in-class P-CAB a game-changer in H. pylori eradication

09 Jun 2026

Glycaemic control in T2D better with CGM vs self-monitoring

08 Jun 2026 by

In adult patients with type 2 diabetes (T2D) receiving basal insulin alongside other glucose-lowering medications, real-time continuous glucose monitoring (CGM) demonstrates superiority over self-monitoring of blood glucose (SMBG) in terms of optimizing glycaemic control, according to the FreeDM2 study.

Glycaemic control in T2D better with CGM vs self-monitoring

08 Jun 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Healthy low-carb, low-fat diets may lower CHD risk

Healthy low-carb, low-fat diets may lower CHD risk

Daraxonrasib makes history in one of the deadliest cancers

Daraxonrasib makes history in one of the deadliest cancers

Oral semaglutide provides limited benefit in individuals with early AD

Oral semaglutide provides limited benefit in individuals with early AD

Product Highlight - Cefuroxime axetil (Cefudyne)

Product Highlight - Cefuroxime axetil (Cefudyne)

Product Highlight - Xylometazoline HCl (Xylomet)

Product Highlight - Xylometazoline HCl (Xylomet)

Product Highlight - Prednisolone (Predzone)

Product Highlight - Prednisolone (Predzone)

Product Highlight - Prednisolone (Neopred)

Product Highlight - Prednisolone (Neopred)

Product Highlight - Multivitamins + Iron (Appetite OB)

Product Highlight - Multivitamins + Iron (Appetite OB)

First-in-class P-CAB a game-changer in H. pylori eradication

First-in-class P-CAB a game-changer in H. pylori eradication

Glycaemic control in T2D better with CGM vs self-monitoring

Glycaemic control in T2D better with CGM vs self-monitoring